EUCTR2008-002121-36-BG进行中（未招募）1 期
A Phase IIb/III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose- Range Finding Clinical Trial of MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 950
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Patient is 21 to 70 years old and currently on a stable dose of insulin for Type 2 Diabetes.
- •HbA1c at visit 4 ( randomization) HbA1c =7.5% and =11.0%
- •BMI > 20kg/m² and <43 kg/m² at visit 1 ( screening)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patient has any history of Type 1 Diabetes; patient is on a weight loss program and is not in the maintenance phase, or patient is taking a weight loss medication (e.g., orlistat, sibutramine, rimonabant) within 8 weeks of Visit 1;patient has undergone surgery within 30 days prior to Visit 1 or has planned major surgery.
研究者
相似试验
进行中（未招募）
1 期
A Phase IIb/III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose- Range Finding Clinical Trial of MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin - Dose-Range Finding Study of MK-0941 in Patients with Type 2 Diabetes on InsuliTreatment of Type 2 DiabetesMedDRA version: 9.1 Level: LLT Classification code 10012601 Term: Diabetes mellitusEUCTR2008-002121-36-DKMerck & Co., Inc.950
进行中（未招募）
1 期
A Phase IIb/III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose- Range Finding Clinical Trial of MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin - Dose-Range Finding Study of MK-0941 in Patients with Type 2 Diabetes on InsuliEUCTR2008-002121-36-FIMSD Finland Oy550
进行中（未招募）
1 期
A Phase IIb/III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose- Range Finding Clinical Trial of MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on InsuliEUCTR2008-002121-36-FRaboratoires Merck Sharp & Dohme-Chibret550
进行中（未招募）
不适用
A Phase IIb/III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-Range Finding Clinical Trial of MK-0941 in Patients With Type 2 Diabetes MellitusWith Inadequate Glycemic Control on Insulin - Dose-Range Finding Study of MK-0941 in Patients with Type 2 Diabetes on InsuliEUCTR2008-002121-36-ATMerck Sharp & Dohme GmbH550
进行中（未招募）
1 期
A Phase IIb/III, Multicenter, Randomized, Double-Blind, Placebo- Controlled Dose-Range Finding Clinical Trial of MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin. - NDType 2 Diabetes Mellitus With Inadequate Glycemic Control on InsulinMedDRA version: 9.1 Level: LLT Classification code 10049746 Term: Insulin-requiring type II diabetes mellitusEUCTR2008-002121-36-ITMERCK & CO., INC.724